ORI-1426

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameORI-1426
Drug Alias NameORI-1426
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolyamine metabolism modulators
TargetsUpdating
Therapy Area/IndicationsProstatic NeoplasmsBreast NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMediquest Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMediquest Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsBreast NeoplasmsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A